Current unemployment for head and neck cancer survivors linked to harder physical work, surgical treatment, and risky alcohol consumption.
An estimated 388,501 survivors of childhood cancer are living in the United States today and nearly one-third of them have a severe, disabling, or life-threatening condition, according to a new study.
Genomic mapping of malignant pediatric adrenocortical tumors has revealed unprecedented details, not only of the aberrant genetic and chromosomal changes that drive the cancer, but the sequence of those changes that trigger it.
An annual report shows steady, if slow, progress in the battle against cancer.
The NCCN Clinical Practice Guidelines in Oncology for Smoking Cessation can help you plan a successful quit program for your patients who smoke.
Second study shows benefits for caregivers with early palliative care intervention.
Prevalence of childhood cancer survivors is increasing, and those who survived at least 5 years beyond diagnosis have at least one comorbidity.
Current research indicates that a rare but aggressive subtype of pediatric acute lymphoblastic leukemia (ALL) has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene.
Breast cancer survivors have a higher risk of developing thyroid cancer, especially within 5 years of their breast cancer diagnosis, according to a national database analysis.
Improved rates of stage-specific treatment for early- and advanced-stage non-small-cell lung cancer (NSCLC) with comorbid COPD were linked to a pulmonologist's management.
Acute lymphoblastic leukemia (ALL) has been found to have two distinct subtypes, and evidence indicates that roughly 13% of ALL cases may be successfully treated with targeted drugs used in the treatment of lymphomas in adults.
U.S. Centers for Disease Control and Prevention (CDC) has determined that sixty-five percent of those with cancer now survive five years or more after diagnosis.
An analysis of data on 945 patients with prostate cancer followed with active surveillance displayed outcome differences, depending on whether the patient was low- or intermediate-risk at diagnosis.
Data from a phase 2 trial supports continuation of trabectedin for patients with advanced soft-tissue sarcoma (STS) who have not progressed after six courses of treatment.
Adult cancer survivors continue to face a variety of unmet needs years after treatment, including anxiety and chronic pain.
Improved survival and treatment response was seen in HPV-16 positive patients.
Investigators linked inherited genetic variations to rapid hearing loss experienced by young cancer patients treated with the drug cisplatin.
Survival has improved, among those of younger age, for patients with cancers of the colon, rectum, breast, prostate, lung, and liver.
A prospective study found that patients with human papillomavirus-related disease had better treatment response than HPV-negative patients.
A new study links a well-known cell communication pathway called Notch to pilocytic astrocytoma (PA), one of the more common brain tumors found in children.
A previous history of cancer cancer did not impact clinical outcomes in advanced lung cancer patients and these patients therefore should be considered for inclusion in clinical trials, according to a study .
Series of focus groups shared their personal experiences with and ideas about smoking cessation.
When participants of a smoking cessation program tweet each other regularly on Twitter, they are more successful at stopping smoking.
When active surveillance is chosen, survival for intermediate-risk disease may be decreased.
Research continues into whether e-cigarettes help smokers quit or actually worsen their habit.
Study shows biggest improvements in post-cancer survival for people diagnosed between ages 50 and 64.
Oncology care teams should provide more guidance on lifestyle change as part of survivorship care, according to recent research.
Variation was observed at a high-volume center when surgeons selected patients with low-risk prostate cancer to undergo radical prostatectomy, according to a study.
Long-lasting effects of cancer can plague patients for years after they complete their treatments. In this study, researchers sought to measure which problems plagued patients the most and for the longest time.
Guideline outlines recommended follow-up care for prostate cancer survivors
Adult survivors of pediatric cancer who underwent brain irradiation at risk for hormone deficiencies
Adult survivors of pediatric cancer are at risk for developing pituitary hormone deficiencies that may worsen their health and quality of life.
Inhibiting the protein Sirtuin1 could play a part in fighting Ewing sarcoma, a common bone cancer in adolescents and children.
Transitions from one stage of cancer care to another are pivotal points of vulnerability for patients. The most significant point comes at the end of treatment, as patients face life forever changed.
New research seeks to better understand why breast cancer spreads to the brain, with the goal of developing a way to reduce the risk of this phenomenon.
A recent, groundbreaking new study found that children of melanoma survivors are not adhering to sun protection recommendations.
A study of approximately 375,000 U.S. women with invasive breast cancer showed differences in likelihood of diagnosis occurring at an early stage, and survival after stage I diagnosis, based on by race and ethnicity.
An intervention aimed at an under-represented group of Latina breast cancer survivors helped encourage better eating habits and nutrition.
The risk of disease recurrence in liver cancer patients who have undergone a liver transplant can now be more accurately calculated, thanks to new tool.
Patients in a a phase III study with higher vitamin D levels demonstrated better outcomes after treatment for their colorectal cancer with chemotherapy and targeted therapy.
Women with stage 1 HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were unlikely to suffer cancer recurrence within 3 years of treatment.
Stereotactic body radiation therapy (SBRT) plus chemotherapy improves survival among patients with stage 4 lung cancer
Combining stereotactic body radiation therapy (SBRT) with a specific chemotherapy regimen more than doubled survival rates for certain patients with stage 4 lung cancer, according to recent research data.
Better understanding of the two distinct processes at the heart of the genetic abnormality driving Ewing sarcoma development could lead to new, more effective therapies.
A new study has better established the future risk of developing breast cancer for those with atypical hyperplasia of the breast.
A new test may reveal which patients will respond to treatment for graft-versus-host disease (GVHD), a serious complication that can arise from stem cell SCT.
According to results of a new, retrospective study, the risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer is double that previously reported.
The Society of Thoracic Surgeons (STS) and the European Society of Thoracic Surgery (ESTS) plan to link their outcomes data on chest procedures, in an effort to improve patient care.
The long-term survival rates following laparoscopic surgery for bladder cancer are not unlike survival rates for open surgery, according to research.
Trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients, according to a large national study.
Use of the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation among patients with lymphoma undergoing a certain type of chemotherapy.
Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.
Many cancer survivors face disease- and treatment-related physical and mental challenges even decades after being cured of their disease.
Biggest increase for time to treatment initiation seen for head and neck cancer patients with advanced disease, chemoradiation, or undergoing treatment at academic center.
Hispanic women in the United States were significantly less likely to survive endometrial uterine cancer than non-Hispanic white women.
There is increasing evidence that adolescent and young adult patients with acute lymphoblastic leukemia (ALL) tend to fare better when treated with high-intensity pediatric protocols than standard adult regimens.
Women over 70 years with early stage breast cancer are very likely to receive radiation therapy, despite evidence of that it might not be the best form of treatment.
Most people know of the traditional use of mistletoe to get a kiss from a loved one during the Christmas holiday. However, US oncologists are discovering a new use for the plant as a CAM treatment for cancer.
Patients with advanced leukemia, when treated with a new type of cancer therapy that blocks mutated IDH2 protein, showed dramatic results in a clinical trial.
Pediatric patients with acute lymphoblastic leukemia (ALL) showed a 90% response rate from the first trials testing an investigational personalized cellular therapy known as CTL019.
Almost half of patients with blood cancer who had relapsed following allogeneic stem cell transplantation benefitted from treatment with the immune checkpoint blocker ipilimumab.
The effectiveness of radiation therapy used to treat head and neck cancer could depend in part on clinician experience, according to a new study.
Is there an effective way to manage the oral side effects of irinotecan therapy?
The first long-term study of a pioneering endoscopic laser treatment for early vocal cord cancer, previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients' tumors.
Women with clear surgical margins after the initial excision are more likely to remain disease-free.
Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning, and other cognitive functions seen in children treated for acute lymphoblastic leukemia (ALL).
More than half of prostate cancer patients age 66 years and older have life expectancies of less than 10 years, yet half of them were over-treated for their prostate cancer with surgery, radiation, or brachytherapy.
Although the use of a radiation treatment that is shorter in duration and less costly has increased among women with early stage breast cancer who underwent breast conserving surgery, most patients who meet guidelines to receive this treatment do not.
Researchers in Germany interviewed more than 2,000 patients with cancer to gather epidemiologic data on mental health of patients with cancer.
Researchers have found that an FDA-approved therapy could be effective in treating both older and African American patients with advanced lung cancer who may not be candidates for chemotherapy.
Organ preservation in kidney cancer more likely at facilities that are early adopters of robotic surgery
Patients with operable kidney cancers were more likely to have a partial nephrectomy, which is the recommended treatment for localized tumors, when treated in hospitals that were early adopters of robotic surgery, according to a new study.
Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival, according to a new study.
Current evidence seems to indicated that withholding T therapy in hypogonadal men cannot be justified.
A new digital program using a Web site and social media aims to meet the unique support needs of women younger than 40 years with breast cancer.
A single academic center performing a high rate of surgical therapy, including total laryngectomy, to treat advanced-stage laryngeal cancer had a higher 5-year survival rate than national levels in a small study.
Fulvestrant did more to improve survival than anastrozole for patients with advanced, hormone receptor-positive breast cancer, according to data.
Study shows need for psychosocial support for patients undergoing hematopoietic stem cell transplant
According to a recent study, patients undergoing hematopoietic stem cell transplantation (HCT) reported a steep problems and substantially worsening depression during hospitalization.
Results from the largest series of male breast cancer cases ever studied shows improvement in male survival, but not equal to that seen in women with breast cancer.
An interventional x-ray guidance device approved by the U.S. Food and Drug Administration in 2013 may have the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy for liver cancer.
Among women with denser breasts, an additional ultrasound can detect breast cancers not discovered by mammogram.
A multigene test was validated as a predictor of risk of disease recurrence among women treated with breast-conserving surgery alone for ductal carcinoma in situ (DCIS), according to data from a large study.
Guanfacine, a medication used to treat hypertension, shows promise as a smoking cessation aid.
In elderly patients with moderate- to high-risk early stage breast cancer for whom standard chemotherapy is too toxic, capecitabine did not improve outcomes when tested as monotherapy, according to recent data.
A key discovery has advanced the understanding of why some patients respond to ipilimumab, an immunotherapy drug, whereas others show less response.
The anticancer drug galeterone has proved successful in lowering prostate-specific antigen levels in men with castration-resistant prostate cancer (CRPC).
A method to determine which patients with ovarian cancer are more likely to respond well to the new anticancer drug rucaparib has been discovered.
Employing financial incentives to encourage smokers to reduce cigarette use can be a successful ploy.
Women with symptoms of serious mental illness are significantly less likely to receive the three routine cancer screenings of Pap tests, mammography, and clinical breast examinations than women in the general population.
Adult survivors of retinoblastoma, a type of eye cancer that usually develops in early childhood, are typically free from long-lasting effects, a new study shows.
Ovarian clear cell adenocarcinoma (CCA), a rare and aggressive form of ovarian cancer, may be treated by employing pelvic radiotherapy (RT).
The surveillance and follow-up of breast cancer survivors has the potential to improve, from the perspective of both patients and the health system.
Significant and durable improvements in insomnia and sleep quality, with and without armodafinil
A genetic test has been developed to identify which men are at higher risk for prostate cancer recurrence after localized treatment with surgery or radiotherapy.
A novel medical-imaging technology, TexRAD, which analyzes the texture of tumors, has been shown in trials to enable early diagnosis of colorectal cancer in patients not responding to the standard cancer therapy better than other available tumor markers.
Prostate cancer patients with hereditary mutations in the BRCA genes do not respond as well to conventional treatment such as surgery and radiotherapy, and they have a lower survival rate than patients who do not have these genetic mutations.
A chemotherapy regimen of procarbazine, lomustine (CCNU), and vincristine (PCV) administered after radiation therapy improved both progression-free survival and overall survival in adults with low-grade gliomas.
A new approach to treatment using a cancer-killing virus combined with a chemotherapy drug may offer hope to those with advanced and recurrent forms of metastatic ovarian cancer.
Nearly one quarter of all women who underwent initial breast conservation surgery (BCS) for breast cancer had a subsequent surgical intervention.
The current classification system for colorectal cancer, based on genetic profiles, cannot be used to predict drug responses to FOLFIRI.
Patients with a specific type of esophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results.
- Vitamin D and prostate cancer: Higher intake improves active surveillance outcomes
- Muscle-building supplements may be associated with testicular cancer
- Triple combination of two targeted therapies + immunotherapy is more effective in advanced melanoma
- Promising drug target identified in medulloblastoma
- Study identifies those at high risk for developing pancreatic cancer
- mHealth app assesses breast cancer risk and aids prevention
- Socioeconomic factors increase mortality after lung cancer surgery
- Half of older U.S. adults take aspirin as preventive medicine
- Cardiorespiratory fitness linked with decreased metabolic syndrome risk among smokers
- Adjuvant chemotherapy in non-small cell lung cancer: State-of-the-art
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|